Transaction in Own Shares

For immediate release 7 February 2007 FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC (the "Company") MARKET PURCHASE OF COMPANY'S OWN SHARES Notification is given, pursuant to the authority granted at the Annual General Meeting of the Company held on 14 July 2006 to make market purchases of the Company's own shares up to an aggregate maximum of 8,630,065, that a market total of 750,000 Ordinary shares of 25p each in the capital of the Company was purchased by the Company today at a price of 490.0p per share. Such shares will be held by the Company as treasury shares. Following this transaction and in conformity with the Transparency Directive's transitional provision 6 the Company hereby notifies the market that; the total number of Ordinary shares held by the Company in treasury following the purchase and non-cancellation of Ordinary shares is 3,277,000; and the total number of Ordinary shares that the Company has in issue, less the total number of Ordinary shares held by the Company in treasury following such purchase, and therefore, the total number of voting rights in the Company is 54,327,881. The figure of 54,327,881 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FSA's Disclosure and Transparency Rules. For and on behalf of Close Investments Limited Company Secretary For further information, please contact: Tracey Lago Close Investments Limited Tel: 020 7426 6219
UK 100

Latest directors dealings